Professor of Biomedical Informatics, Harvard Medical School
Professor of Medicine, Brigham and Women’s Hospital
Dr. Sunyaev
is a computational genomicist and geneticist. Research in his lab encompasses
many aspects of population genetic variation including the origin of mutations,
the effect of allelic variants on molecular function, population and
evolutionary genetics, and genetics of human complex and Mendelian traits. He
developed several computational and statistical methods widely adopted by the
community.
Dr. Sunyaev
obtained a PhD in molecular biophysics from the Moscow Institute of Physics and
Technology and completed his postdoctoral training in bioinformatics at the
European Molecular Biology Laboratory (EMBL). He is an Associate Member at
Broad Institute of MIT and Harvard. He co-leads the NHGRI-funded Genome
Sequencing Program Analysis Center and is actively involved in the Undiagnosed
Diseases Network and in the Brigham Genomic Medicine program. He also
co-organizes the Boston Evolutionary Genomics Group.
Professor of Biomedical Informatics, Harvard Medical School
Professor of Medicine, Brigham and Women’s Hospital
Dr. Sunyaev
is a computational genomicist and geneticist. Research in his lab encompasses
many aspects of population genetic variation including the origin of mutations,
the effect of allelic variants on molecular function, population and
evolutionary genetics, and genetics of human complex and Mendelian traits. He
developed several computational and statistical methods widely adopted by the
community.
Dr. Sunyaev
obtained a PhD in molecular biophysics from the Moscow Institute of Physics and
Technology and completed his postdoctoral training in bioinformatics at the
European Molecular Biology Laboratory (EMBL). He is an Associate Member at
Broad Institute of MIT and Harvard. He co-leads the NHGRI-funded Genome
Sequencing Program Analysis Center and is actively involved in the Undiagnosed
Diseases Network and in the Brigham Genomic Medicine program. He also
co-organizes the Boston Evolutionary Genomics Group.
Journal article
The complications with identifying cells at the origin of cancer and tracking their early divisions impede studies of cancer initiation. Recently, it was shown that some DNA lesions generated by a pulse of damage-inducing mutagen persist over multiple rounds of replication. Segregation of DNA lesions in the early genealogy of an expanding clone leaves a statistically interpretable footprint of cancer initiating events. Specifically, it allows for estimating the number of cell divisions between...
Journal article
CONCLUSION: This study provides an evidence-based framework for variant prioritization in ES and GS data using Exomiser and Genomiser. These recommendations have been implemented in the Mosaic platform to support the ongoing analysis of undiagnosed UDN participants and provide efficient, scalable reanalysis to improve diagnostic yield. Our work also highlights the importance of tracking solved cases and diagnostic variants that can be used to benchmark bioinformatics tools. Exomiser and...